These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31522880)

  • 1. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
    Gillmann C; Jäkel O; Karger CP
    Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
    Gillmann C; Jäkel O; Schlampp I; Karger CP
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response curves for MRI-detected radiation-induced temporal lobe reactions in patients after proton and carbon ion therapy: Does the same RBE-weighted dose lead to the same biological effect?
    Gillmann C; Lomax AJ; Weber DC; Jäkel O; Karger CP
    Radiother Oncol; 2018 Jul; 128(1):109-114. PubMed ID: 29459152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of enhancements in the local effect model (LEM) on the predicted RBE-weighted target dose distribution in carbon ion therapy.
    Grün R; Friedrich T; Elsässer T; Krämer M; Zink K; Karger CP; Durante M; Engenhart-Cabillic R; Scholz M
    Phys Med Biol; 2012 Nov; 57(22):7261-74. PubMed ID: 23075883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy.
    Steinsträter O; Grün R; Scholz U; Friedrich T; Durante M; Scholz M
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):854-60. PubMed ID: 22483698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sensitivity of radiobiological models in carbon ion radiotherapy (CIRT) and its consequences on the clinical treatment plan: Differences between LEM and MKM models.
    Góra J; Grosshagauer S; Fossati P; Mumot M; Stock M; Schafasand M; Carlino A
    J Appl Clin Med Phys; 2024 Jul; 25(7):e14321. PubMed ID: 38436509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model.
    Zhang L; Wang W; Hu J; Lu J; Kong L
    Radiat Oncol; 2020 Dec; 15(1):277. PubMed ID: 33302998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy.
    Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M
    Med Phys; 2024 Jun; 51(6):3950-3960. PubMed ID: 38696546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems.
    Molinelli S; Magro G; Mairani A; Matsufuji N; Kanematsu N; Inaniwa T; Mirandola A; Russo S; Mastella E; Hasegawa A; Tsuji H; Yamada S; Vischioni B; Vitolo V; Ferrari A; Ciocca M; Kamada T; Tsujii H; Orecchia R; Fossati P
    Radiother Oncol; 2016 Aug; 120(2):307-12. PubMed ID: 27394694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of potential advantages of relevant ions for particle therapy: a model based study.
    Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
    Med Phys; 2015 Feb; 42(2):1037-47. PubMed ID: 25652516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
    Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
    Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy.
    Fossati P; Molinelli S; Matsufuji N; Ciocca M; Mirandola A; Mairani A; Mizoe J; Hasegawa A; Imai R; Kamada T; Orecchia R; Tsujii H
    Phys Med Biol; 2012 Nov; 57(22):7543-54. PubMed ID: 23104051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes.
    Molinelli S; Bonora M; Magro G; Casale S; Dale JE; Fossati P; Hasegawa A; Mirandola A; Ronchi S; Russo S; Preda L; Valvo F; Orecchia R; Ciocca M; Vischioni B
    Radiother Oncol; 2019 Dec; 141():227-233. PubMed ID: 31522881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionated carbon ion irradiations of the rat spinal cord: comparison of the relative biological effectiveness with predictions of the local effect model.
    Saager M; Glowa C; Peschke P; Brons S; Grün R; Scholz M; Debus J; Karger CP
    Radiat Oncol; 2020 Jan; 15(1):6. PubMed ID: 31900185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RBE-weighted dose conversions for carbon ionradiotherapy between microdosimetric kinetic model and local effect model for the targets and organs at risk in prostate carcinoma.
    Wang W; Huang Z; Sheng Y; Zhao J; Shahnazi K; Zhang Q; Jiang G
    Radiother Oncol; 2020 Mar; 144():30-36. PubMed ID: 31710941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine.
    Guan X; Gao J; Hu J; Hu W; Yang J; Qiu X; Hu C; Kong L; Lu JJ
    Radiat Oncol; 2019 Nov; 14(1):206. PubMed ID: 31752953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calibration and evaluation of the relative biological effectiveness for carbon-ion radiotherapy in a new relative to a clinically applied treatment planning system.
    Wang W; Huang Z; Sun W; Wang X; Zhao J; Shen H
    Radiat Oncol; 2022 Dec; 17(1):219. PubMed ID: 36587224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
    Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
    Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Scholz M; Kraft G; Wannenmacher M; Debus J
    Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.